Business Context and Reporting Period
This Form 8-K is a Current Report filed by Autonomix Medical, Inc. on January 22, 2025. The filing serves as a Regulation FD disclosure regarding a presentation by the Company's Chief Executive Officer, Brad Hauser, at the "Virtual Investor Closing Bell Series" held on the same date. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market under the symbol AMIX.
Financial Metrics
This filing does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely references a previously announced investor presentation and the availability of a webcast replay.
Guidance, Outlook, and Risks
- Management Commentary: The filing incorporates by reference a conference presentation (Exhibit 99.1) containing forward-looking statements regarding the Company's future expectations.
- Risks and Uncertainties: The document explicitly warns that forward-looking statements involve known and unknown risks. Investors are directed to review the "Risk Factors" in the offering circular filed on January 26, 2024, and subsequent Form 10-Q filings.
- Disclaimer: The Company states it undertakes no obligation to update forward-looking statements to reflect events occurring after the date of the presentation.
Key Facts for Investor Verification
- Verify the content of the "Virtual Investor Closing Bell Series" presentation attached as Exhibit 99.1 for specific strategic updates.
- Review the offering circular filed on January 26, 2024, and recent Form 10-Q filings for detailed risk factors and financial status.
- Confirm the availability of the webcast replay on the Company's investor website, accessible for 90 days following the event.
- Note that this 8-K filing itself contains no audited or unaudited financial statements.